Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

Direct Payment

$108,333.00

Deciphering the role of Nlrp10 in dendritic cells during influenza infection

FY 2013-14

Summary
Influenza A has afflicted humans for centuries, and remains a major threat for human health. Because of its high mutation rate, protection by a yearly influenza vaccine is transient. New vaccine and new strategy for the treatment are highly needed for global control of this disease. However, due to lack of fundamental information about how this virus interacts with our immune system, the clinical prevention for emerging highly virulent H5N1 avian flu and a pandemic variant of human influenza is hampered. Antigen presenting cells, especially dendritic cells(DC), play a central role in initiating anti-viral immune response, so targeting DCs is one potential way to enhance anti-influenza immunity. DCs represent an extremely heterogeneous population of cells with the various subsets defined by their specific surface molecules and resident locations. Upon influenza infection, two major DC subsets pick up viral antigens and/or live virus and migrate to local draining lymph nodes to initiate anti-viral immune responses. There is evidence that these two DC subsets play distinct roles in priming adaptive immunity. However, due to the lack of appropriate biological tools, the exact role of these two subsets in the activation of anti-viral cytotoxic T cells remains controversial. We have demonstrated that we could paralyze one DC subset by knocking out a newly identified pattern recognition receptor, Nlrp10, which provided a unique tool for us to specifically dissect the role of these two DC subsets in influenza infection. By using this useful mouse model, we will be able to address critical questions about the role of Nlrp10 in DCs during influenza infection, and dissect the exact role of different DC subsets using this unique mouse model. Answers to these fundamental questions have not only basic value in terms of our understanding the immune response against this highly pathogenic human pathogen, but also implication for new vaccine design and potential drug targets.
Program
CIHR Fellowship
Location
Connecticut, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
301440
Name
Liu Dong
Region
Connecticut
Country
United States of America
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Deciphering the role of Nlrp10 in dendritic cells during influenza infection
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$108,333
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Cytotoxic T Lymphocyte; Dendritic Cell; Immunity; Viral Infection
Abstract
Influenza A has afflicted humans for centuries, and remains a major threat for human health. Because of its high mutation rate, protection by a yearly influenza vaccine is transient. New vaccine and new strategy for the treatment are highly needed for global control of this disease. However, due to lack of fundamental information about how this virus interacts with our immune system, the clinical prevention for emerging highly virulent H5N1 avian flu and a pandemic variant of human influenza is hampered. Antigen presenting cells, especially dendritic cells(DC), play a central role in initiating anti-viral immune response, so targeting DCs is one potential way to enhance anti-influenza immunity. DCs represent an extremely heterogeneous population of cells with the various subsets defined by their specific surface molecules and resident locations. Upon influenza infection, two major DC subsets pick up viral antigens and/or live virus and migrate to local draining lymph nodes to initiate anti-viral immune responses. There is evidence that these two DC subsets play distinct roles in priming adaptive immunity. However, due to the lack of appropriate biological tools, the exact role of these two subsets in the activation of anti-viral cytotoxic T cells remains controversial. We have demonstrated that we could paralyze one DC subset by knocking out a newly identified pattern recognition receptor, Nlrp10, which provided a unique tool for us to specifically dissect the role of these two DC subsets in influenza infection. By using this useful mouse model, we will be able to address critical questions about the role of Nlrp10 in DCs during influenza infection, and dissect the exact role of different DC subsets using this unique mouse model. Answers to these fundamental questions have not only basic value in terms of our understanding the immune response against this highly pathogenic human pathogen, but also implication for new vaccine design and potential drug targets.
Competitiondate
201311
Approvedterm2
2 yrs 2 mths
Pinamesdelim
Liu, Dong
Approvedterm
2 ans 2 mois
Cihrcontribution2
~ $108,333~ $0~
Direct Payment - $108,333 Grant (2013-14) | Canada Spends